Samsung’s new blockchain pilots are all about transparently tracking medicine

Cointelegraph

Published Sep 25, 2020 01:00PM ET

Updated Sep 26, 2020 03:00PM ET

Samsung (KS:005930) SDS will conduct a series of pilot projects in November to test blockchain-powered medicine distribution management. The goal of these tests is to guarantee transparency in the process of tracking pharmaceutical drugs.

According to Yankup, the IT branch of Samsung Group announced the pilot programs, named “Disruptive innovation technology for tracking drug distribution history,” at the BioPharma Cold Chain Logistics session in Seoul, South Korea.

Continue Reading on Coin Telegraph